Online Medical Classes - American Association For Medical Transcription News

American Association For Medical Transcription News

Gene Involved In Fuchs Corneal Dystrophy Is Found Thursday, August 26, 2010 @ 7:33AMA 13-member research team led by University of Oregon scientist Dr. Albert O. Edwards has found a gene likely responsible for Fuchs corneal dystrophy, an inheritable genetic disorder and leading cause of corneal transplant operations. Edwards performed a genome-wide analysis comparing patients with and without typical age-related Fuchs, finding an alteration in the transcription-factor-4 gene ...
Gene involved in Fuchs corneal dystrophy is found Thursday, August 26, 2010 @ 12:14AMA research team has found a gene likely responsible for Fuchs corneal dystrophy, an inheritable genetic disorder and leading cause of corneal transplant operations.
Gene Involved in Fuchs Corneal Dystrophy Is Found Wednesday, August 25, 2010 @ 5:25PMA 13-member research team led by a University of Oregon medical scientist has found a gene likely responsible for Fuchs corneal dystrophy, an inheritable genetic disorder and leading cause of corneal transplant operations.
Gene involved in Fuchs corneal dystrophy is found Wednesday, August 25, 2010 @ 4:31PMA 13-member research team led by University of Oregon scientist Dr. Albert O. Edwards has found a gene likely responsible for Fuchs corneal dystrophy, an inheritable genetic disorder and leading cause of corneal transplant operations.
Genome Scanning Finds Genes For Cholesterol And Heart Disease That Could Be Important Targets For Treatment Thursday, August 5, 2010 @ 7:20AMTwo international studies published in a leading journal this week have pinpointed genes for cholesterol and heart disease that could be important targets for treatment, and demonstrate the potential clinical value of "genome scanning" or GWAS, genome wide association studies, in developing new diagnostic tests and therapies for diseases with genetic risks...
Alnylam Scientists Contribute to Discovery of a New Disease Gene in Cardiovascular Disease Thursday, August 5, 2010 @ 7:12AMCAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, announced today the publication of new research findings in the journal Nature describing the discovery and validation of the role of the gene Sort1 in the development of cardiovascular disease, including myocardial infarction (MI). This work was done with collaborators at ...
Alnylam Scientists Contribute to Discovery of a New Disease Gene in Cardiovascular Disease Thursday, August 5, 2010 @ 7:00AMCAMBRIDGE, Mass.----Alnylam Pharmaceuticals, Inc. , a leading RNAi therapeutics company, announced today the publication of new research findings in the journal Nature describing the discovery and validation of the role of the gene Sort1 in the development of cardiovascular disease, including myocardial infarction .
Boston court deals 2 blows to Defense of Marriage Act Friday, July 9, 2010 @ 2:10AMA U.S. judge in Boston has ruled that a federal gay-marriage ban is unconstitutional because it interferes with the right of a ...
Gay marriage ban struck down Friday, July 9, 2010 @ 12:11AMboston Judge: Federal law is unconstitutional The federal law banning gay marriage is unconstitutional because it interferes with the right of a state to define the institution and therefore denies married gay couples some federal benefits, a federal judge ruled yesterday in Boston. U.S. District Judge Joseph Tauro ruled in favor of gay couples' rights in two separate challenges to the Defense ...
A-Life Medical, Inc. Expands Growing Network of Professionals with New Appointments and Promotion Monday, June 28, 2010 @ 4:00AMSAN DIEGO----A-Life Medical, Inc., the pioneer and leading provider of computer-assisted coding products and services to the healthcare industry, announced today that it has named three new directors and promoted its engineering manager, all in an effort to fuel the company’s continued, rapid growth.
Epigenetic Gene Silencing May Hold Key To Fatal Lung Vascular Disease Tuesday, June 8, 2010 @ 6:27AMA rare but fatal disease of blood vessels in the lung may be caused in part by aberrant silencing of genes rather than genetic mutation, new research reports. Pulmonary arterial hypertension, a syndrome characterized by gradual blockage of blood vessels in the lungs, has been linked to genetic causes in a small percentage of patients. But University of Chicago researchers have now found that a ...
Death star Wednesday, May 26, 2010 @ 12:35PMA fax that Michael Hengartner sent to his mentor helped turn apoptosis into a Nobel Prize-winning pathway
Androgen receptors promote hepatitis B virus in growth and development of hepatoma cells Thursday, May 20, 2010 @ 5:25AMDr. Ming-Heng Wu of the Institute of Basic Medical Sciences at National Cheng Kung University (NCKU), Taiwan, in collaboration with Prof. Chawnshang Chang's laboratory of University of Rochester (UR), United States, have discovered that androgen receptors (AR) can promote hepatitis B virus-induced hepatocarcinogenesis through modulation of hepatitis B virus (HBV) RNA transcription.
Cutting-Edge Research Presented During Digestive Disease Week Tuesday, May 4, 2010 @ 7:28AMClinicians, researchers and scientists from around the world will gather for Digestive Disease Week® 2010 (DDW), the largest and most prestigious gastroenterology meeting, from May 1 to May 5, 2010, at the Ernest N. Morial Convention Center, New Orleans, LA. DDW is the annual meeting of the American Gastroenterological Association (AGA) Institute, the largest and oldest GI society in the world ...
Removable methyl groups on specific genes of autistic individuals that led to gene silencing identified Thursday, April 22, 2010 @ 5:06AMA new study by researchers at The George Washington University School of Medicine and Health Sciences' Department of Biochemistry and Molecular Biology raises hope that autism may be more easily diagnosed and that its effects may be more reversible than previously thought.
Cyclacel's Innovative and Diverse Oncology Targeted Pipeline Highlighted in Six Presentations at AACR Annual Meeting Tuesday, April 20, 2010 @ 1:00PMBERKELEY HEIGHTS, N.J. -- Cyclacel Pharmaceuticals, Inc. , a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious disorders, today announced the presentation of preclinical results for several of its pipeline compounds during the American Association of Cancer Research 101st Annual Meeting 2010 in ...
NanoString Technologies launches new miRNA assay kits Tuesday, April 20, 2010 @ 3:53AMNanoString Technologies, Inc., a privately held life sciences company marketing a complete solution for detecting and counting large sets of target molecules in biological samples, today announced a unique new product for miRNA analysis that includes a multiplexed assay for profiling the human miRNA transcriptome in a single tube. The company introduced the new assay kit, which expands the ...
Radiolabeled hedgehog can differentiate stem-like cancer cells and identify aggressive tumors Monday, April 19, 2010 @ 4:18AMAt the American Association for Cancer Research 101st Annual Meeting 2010, scientists and clinicians will present more than 6,300 abstracts dealing with innovative aspects of biology, technology and emerging therapies.
Idera Pharmaceuticals Announces Positive Phase 1 Data of IMO-2125 in Null Responder HCV Patients at EASL 2010 Thursday, April 15, 2010 @ 10:30AMCAMBRIDGE, Mass.----Idera Pharmaceuticals, Inc. announced today that positive interim data from a Phase 1 clinical trial of IMO-2125, a Toll-like Receptor 9 agonist, in null responder patients with chronic hepatitis C virus infection were presented at the 45th Annual Meeting of the European Association for the Study of the Liver .
Dolbey Completes Phase One of Fusion CAC Implementation at Adventist Health System Tuesday, April 13, 2010 @ 3:44PMWASHINGTON----Today at the American Health Information Management Association’s Computer-Assisted Coding Summit, Dolbey announced that it has completed, along with Artificial Medical Intelligence, the first phase of its Fusion CAC™ implementation at Adventist Health System in Orlando, Florida.
The AACR Presents the Fourth Annual Margaret Foti Award to Phillip A. Sharp, Ph.D. Tuesday, April 13, 2010 @ 12:41PMPhillip A. Sharp, Ph.D., institute professor at the David H. Koch Institute for Integrative Cancer Research at the Massachusetts Institute of Technology (MIT), will receive the fourth annual American Association for Cancer Research Margaret Foti Award for Leadership and Extraordinary Achievements in Cancer Research at the AACR 101st Annual Meeting 2010.
Arterial ischemic stroke in children often go unrecognized, and the strokes can recur Thursday, February 25, 2010 @ 1:11AMChildren can have strokes, and the strokes can recur, usually within a month, according to pediatric researchers. Unfortunately, the strokes often go unrecognized the first time, and the child does not receive treatment before the recurrence.
Arsenic Exposure Activates an Oncogenic Signaling Pathway; Leads to Increased Cancer Risk Tuesday, February 23, 2010 @ 1:29PM1) Arsenic acts as a co-carcinogen by inducing Hedgehog activity; 2) Arsenic alters Hedgehog signaling and targets a transcription factor; 3) Exposure functions as a carcinogen for lung, skin and bladder cancers.
Arsenic exposure activates an oncogenic signaling pathway; leads to increased cancer risk Tuesday, February 23, 2010 @ 1:21PMResearchers have found a new oncogenic signaling pathway by which the environmental toxin arsenic may lead to adverse health effects, including bladder cancer.
Mirna Therapeutics receives ETF award to develop miRNA therapeutics for multiple cancers Monday, January 11, 2010 @ 2:23AMMirna Therapeutics announced today that the Company received a $5 million award from the State of Texas through the Texas Emerging Technology Fund (“ETF”). The ETF was created with the goal of growing new and existing businesses to accelerate the introduction of new products and services in the marketplace. This is the largest award of this type that has ever been granted.
Mirna Therapeutics Announces $5 Million Award from Texas Emerging Technology Fund Monday, January 11, 2010 @ 1:00AMAUSTIN, Texas----Mirna Therapeutics announced today that the Company received a $5 million award from the State of Texas through the Texas Emerging Technology Fund . The ETF was created with the goal of growing new and existing businesses to accelerate the introduction of new products and services in the marketplace.
Physician offices projected to see a decade of significant job growth Sunday, January 10, 2010 @ 8:53PMConcern is high that work force shortages will persist and that paying for additional staff will be challenging.
Study shows diabetic patients can benefit from gastric bypass surgery Tuesday, January 5, 2010 @ 10:33PMBariatric surgery is a procedure designed to help patients lose weight, but an unexpected side effect is that it can also help rid patients of diabetes.
NEWSBRIEF: Cepheid s US Army Contract Boosted By $3.4 Million Thursday, December 17, 2009 @ 6:05PMNEW YORK, May 9-Cepheid said today that its contract with the U.S. Army's infectious disease research division has been extended for $3.4 million over the next two years.
$9.68 Million Supports Innovative Cancer Research By 13 Young Scientists Wednesday, December 9, 2009 @ 5:56AMStand Up To Cancer (SU2C) announced recently that it is awarding $9.68 million to support high-risk/high-reward cancer research conducted by 13 young scientists. Over a three-year period, each investigator will receive a total of up to $750,000 as part of SU2C's Innovative Research Grants program, which supports the next generation of cancer research leaders. "We asked our best and brightest ...
Stand Up To Cancer funds student research Monday, December 7, 2009 @ 6:00PMStand Up To Cancer funds student research
Stand Up To Cancer Funds High-risk/High-reward Cancer Research by 13 Young Scientists Monday, December 7, 2009 @ 6:00AMStand Up To Cancer announced today that it is awarding $9.68 million to support high-risk/high-reward cancer research conducted by 13 young scientists. Over a three-year period, each investigator will receive a total of up to $750,000 as part of SU2C's Innovative Research Grants program, which supports the next generation of cancer research leaders.
Stand Up To Cancer Funds High-Risk/High-Reward Cancer Research by 13 Young Scientists Monday, December 7, 2009 @ 12:21AMDec. 7, 2009, New York, N.Y./Los Angeles, Calif.: Stand Up To Cancer (SU2C) announced today that it is awarding $9.68 million to support high-risk/high-reward cancer research conducted by 13 young scientists. Over a three-year period, each investigator will receive a total of up to $750,000 as part of SU2C's Innovative Research Grants program, which supports the next generation of cancer ...
Researchers "Notch" A Victory Toward New Kind Of Cancer Drug Thursday, November 12, 2009 @ 6:26AMScientists have devised an innovative way to disarm a key protein considered to be "undruggable," meaning that all previous efforts to develop a drug against it have failed.
Researchers "Notch" a Victory Toward New Kind of Cancer Drug Wednesday, November 11, 2009 @ 1:32PMNew molecule neutralizes key protein, once thought to be "undruggable," with roles in leukemia and other cancers
Researchers 'notch' a victory toward new kind of cancer drug Wednesday, November 11, 2009 @ 12:26PM( Broad Institute of MIT and Harvard ) Scientists have devised an innovative way to disarm a key protein considered to be "undruggable," meaning that all previous efforts to develop a drug against it have failed. Their discovery lays the foundation for a new kind of therapy aimed directly at a critical human protein -- one of a few thousand so-called transcription factors -- that could someday ...
Scientists Identify Specific Markers That Trigger Aggressiveness Of Liver Cancer Wednesday, October 21, 2009 @ 7:19AMPatients with Positive Epithelial-Mesenchymal Transition Markers Have Lowest Survival Rate Hepatocellular carcinoma (HCC) or primary liver cancer forms in the epithelial tissue of the liver and is most commonly caused by the hepatitis B virus (HBV) or hepatitis C virus (HCV). In the U.S.
Scientists identify specific markers that trigger aggressiveness of liver cancer Tuesday, October 20, 2009 @ 1:24PMHepatocellular carcinoma (HCC) or primary liver cancer forms in the epithelial tissue of the liver and is most commonly caused by the hepatitis B virus (HBV) or hepatitis C virus (HCV). In the U.S., the National Cancer Institute (NCI) estimates that 15,000 men and 6,000 women are diagnosed with HCC each year. Worldwide, HCC accounts for 632,000 cases with the highest regions being Western ...
Paratek Pharmaceuticals Signs Worldwide License and Commercialization Agreement for PTK 0796, Broad-Spectrum Oral and ... Thursday, October 8, 2009 @ 6:00AMParatek Pharmaceuticals, Inc. announced today that it has entered into an exclusive worldwide collaborative development, manufacturing and commercialization license agreement with Novartis for Paratek's lead broad-spectrum antibiotic, PTK 0796, a first-in-class aminomethylcycline in Phase 3 clinical trials.
Axel Ullrich receives the 2009 Dr. Paul Janssen Award for Biomedical Research Tuesday, September 8, 2009 @ 1:54AMJohnson & Johnson today honored the career achievements of Axel Ullrich, Ph.D., with the 2009 Dr. Paul Janssen Award for Biomedical Research. Dr. Ullrich received this award for his scientific discoveries that led to innovative new drugs including Herceptin((R)) (trastuzumab)*, a personalized medicine therapy, which was the first to target a specific type of breast cancer.
Stroke Survivor Talks Prevention to African-American Community and Anybody Who Will Listen Wednesday, August 12, 2009 @ 8:52AMGreg Traylor was just 46 years old when he suffered a debilitating stroke. Today, he's on a mission to raise stroke prevention awareness in the African-American community. According to the National Stroke Association, African-Americans are affected by stroke more often than any other group. They are twice as likely as Caucasians to die from stroke, and one half of all African-American women will ...
People in the News Friday, August 7, 2009 @ 2:11PMRafael Irizarry received President's Award by the Committee of Presidents of Statistical Societies in "recognition of outstanding contributions to the statistics profession," according to the announcement.
Noninsulin-producing alpha cells in the pancreas can be converted to insulin-producing beta cells Thursday, August 6, 2009 @ 5:02PMIn findings that add to the prospects of regenerating insulin-producing cells in people with type 1 diabetes, researchers in Europe -- co-funded by the Juvenile Diabetes Research Foundation -- have shown that insulin-producing beta cells can be derived from non-insulin-producing cells in the pancreas.
Featherstone Informatics Group, Inc. Named Exclusive Vendor for the American College of Cardiology's Practice-Based ... Tuesday, August 4, 2009 @ 2:10AMWASHINGTON, Aug. 3 /PRNewswire/ -- Featherstone Informatics Group, Inc.
Featherstone Informatics Group, Inc. Named Exclusive Vendor for the American College of Cardiology's Practice-Based ... Monday, August 3, 2009 @ 9:01PMFeatherstone Informatics Group, Inc. today announced that they have been chosen as the exclusive vendor for the American College of Cardiology's practice-based quality improvement program, called the IC3 Program® .
Myriad, Defendants' Motion to Dismiss ACLU Lawsuit Set for Hearing Monday, August 3, 2009 @ 2:56PMNEW YORK (GenomeWeb News) – A recent motion to dismiss a lawsuit brought by the American Civil Liberties Union and other plaintiffs against the US Patent Office and Myriad Genetics, among other defendants, has been scheduled to be heard by the court on Sep. 30, according to documents filed last week.
Discovery Of Genetic Toggle Switch Inches Closer To Possible Diabetes Cure Monday, July 27, 2009 @ 9:25AMScientists have identified a master regulator gene for early embryonic development of the pancreas and other organs, putting researchers closer to coaxing stem cells into pancreatic cells as a possible cure for type 1 diabetes. Besides having important implications in diabetes research, the study offers new insights into certain congenital birth defects.
Bcl6 Gene Sculpts Helper T Cell To Boost Antibody Production Friday, July 24, 2009 @ 7:19AMExpression of a single gene programs an immune system helper T cell that fuels rapid growth and diversification of antibodies in a cellular structure implicated in autoimmune diseases and development of B cell lymphoma, scientists at The University of Texas M. D. Anderson Cancer Center reported today in Science Express, the advance online publication of the journal Science.
DeCODE-led Megastudy Finds New Genetic Clues To Causes Of Schizophrenia Thursday, July 2, 2009 @ 6:25AMThe largest study of the genetics of schizophrenia ever undertaken has revealed several new common single-letter variants in the sequence of the human genome (SNPs) linked to risk of the disease.
Bottom Line Tuesday, June 30, 2009 @ 5:51PM• AGRICULTURE. K&L Gates is lobbying for the Alliance for a Green Revolution in Africa. Former Rep. James Walsh (R-N.Y.) is lobbying the executive branch on behalf of the alliance, lobbying records show.